SUMMARY To test the hypothesis that coronary artery bypass grafting (CABG) is not routinely required in patients undergoing aortic valve replacement (AVR) who have coexistent coronary artery disease (CAD), we compared the results of operation in 55 consecutive symptomatic patients who had CAD and underwent AVR without CABG with results in another 142 patients without CAD who underwent AVR during the same period, and with published results from other centers in which CABG was used in patients with CAD who underwent AVR. Operative mortality was 4% in patients with CAD and 5% in patients without CAD. Late survival was not significantly different between the two groups when analyzed for the entire population (80% survival at 3 years in CAD patients, 82% for non-CAD patients), or for the subgroup of patients with aortic stenosis, aortic regurgitation or aortic stenosis plus regurgitation. Eight patients with CAD (15%) developed recurrent angina after AVR (mean follow-up 43 months); only three patients (6%) required CABG because of medically refractory angina (12-43 months). Operative mortality, operative infarction (9%), recurrent angina and long-term survival in patients with CAD after AVR were similar to those at other centers after AVR plus CABG. These data suggest that preoperative detection of CAD does not necessitate CABG in all patients at the time of AVR. 
valvular or aortic root disease that required repair at the time of aortic valve replacement. Two hundred ten patients fulfilled the selection criteria. No patient at our institution during this period was denied operation or excluded from the current study because of severe congestive heart failure or poor left ventricular function. Aortic valvular disease was evaluated before operation by right-and left-heart catheterization. The diagnosis of preponderant aortic stenosis was made in patients with peak aortic valve gradients greater than 50 mm Hg and less-than-moderate valvular regurgitation (failure of the cardiac apex to opacify during aortic root cineangiography). Preponderant aortic regurgitation was defined as moderate-to-severe valvular regurgitation on aortic root cineangiography (early opacification of the cardiac apex that did not clear during the subsequent cardiac cycle) in patients with peak valve gradients less than 30 mm Hg. Combined aortic stenosis plus regurgitation was defined as moderate-to-severe valvular regurgitation in patients with peak valve gradients of 30 mm or greater.
Coronary artery anatomy was assessed in 182 of 210 patients (87%) by preoperative coronary cineangiography (148 patients), postoperative coronary cineangiography (27 patients) or autopsy examination (seven patients). Of the 28 patients whose coronary anatomy was not defined, 19 were younger than 35 years of age and coronary arteriography was not considered indicated on the basis of age and clinical presentation; in the other nine patients (ages 43-72 years), data were unavailable. The 28 patients in whom coronary anatomy was not defined were included for analysis in the group of patients without coronary artery disease; all these patients are alive after operation, and none has developed recurrent angina pectoris. Some of these 28 patients may have had coronary artery disease at the time of operation (especially the nine patients aged 35 years or older), which would weight the survival analyses in favor of the group without coronary artery disease and against the group with coronary disease.
Sixty-eight of the 210 patients (32%) had coexistent coronary artery disease, defined as . 50% stenosis (as judged by maximal reduction in luminal diameter) of at least one major coronary artery. Our protocol policy was to refrain from performing a bypass on the coronary arteries at the time of aortic valve replacement in patients with coexistent coronary artery disease, except in patients with > 50% stenosis of the left main coronary artery (n = 6) and in patients whose aortic valve disease was mild (< 50 mm peak valve gradient and less-than-moderate regurgitation), who we believed might not derive improvement in angina after valve replacement alone (n = 5). Coronary bypass was also performed in one patient with a discrete left ventricular aneurysm that required aneurysmectomy at the time of valve replacement and in one patient with aortic stenosis and coronary artery disease whose valve gradient could not be measured at catheterization. Thus, 13 patients underwent combined valve replacement plus myocardial revascularization, and they are excluded from further analysis.
The the number of such assays was insufficient to aid in assessing the incidence of operative infarction.
Patient Follow-up
The follow-up period after operation ranged from 9 months to 7.8 years (mean 3.7 years). All patients who survived 6 Finally, long-term survival of patients with coronary artery disease after aortic valve replacement alone in the current series (4-year survival of 74%) was compared to that of patients after combined aortic valve replacement plus myocardial revascularization reported from the Cleveland Clinic (3½/2-year survival of 65%),' University of Oregon (4-year survival of 74%)2 and University of Alabama (4-year survival of 74%).3 The four survival curves were not significantly different ( fig. 3 ).
Discussion
Coronary artery disease coexists with aortic valve disease in many patients who require aortic valve replacement." -'4 Early studies identified these patients as a group with a higher operative mortality and a poorer long-term prognosis after operation than patients without associated coronary disease."
Hence, modifications either in the timing of operation or in operative techniques (such as combining coronary artery bypass with valve replacement) appeared necessary to improve the outlook of such patients. The results of aortic valve replacement without myocardial revascularization in our 55 patients with associated coronary artery disease bear directly on this problem. In these patients, in whom aortic valvular disease was as hemodynamically severe as in 142 other patients without coronary artery disease (table 1), operative mortality was similar to that in the patients without coronary artery disease (4% vs 5%). AVR Alone Moreover, the incidence of operative myocardial in-NIH (1972) (1973) (1974) (1975) (1976) (1977) (1978) farction in patients with coronary artery disease (9%) R Univ. Alabama (1970 Alabama ( -1977 was no greater than in patients without coronary dis--&&-Univ. Oregon (1970 Oregon ( -1977 ease (8%). The incidence of operative infarction by -0-C-Cleveland Clinic (1967) (1968) (1969) (1970) (1971) (1972) ECG in our patients without coronary artery disease falls within the range previously reported (1-14%) for patients without coronary disease undergoing aortic I valve replacement using the same myocardial preser- The presence of coronary artery disease also did not adversely influence survival among the subgroups of patients with aortic stenosis, aortic regurgitation and r, some of the first series of combined aortic aortic stenosis and regurgitation ( fig. 2) . Moreover, placement and myocardial revascularization when patients with aortic regurgitation were further operative mortality that was much higher divided into subgroups with normal and subnormal either procedure alone.'-"'8 Because the addiechocardiographic left ventricular function (resulting -oronary artery bypass might have increased in subgroups with good and with poor long-term postof valve replacement, based on these early operative prognosis), coronary artery disease did not and because it had not been proved that corosignificantly affect long-term survival within each subery bypass plus valve replacement improved group (table 5) 20 22 Second, in two of the three patients in the current study who required late coronary bypass surgery after initial aortic valve replacement, coronary artery disease progressed, with critical stenoses developing in arteries that would not have been bypassed at the time of the first operation.
Similar observations have been mnade in patients without aortic valve disease after myocardial revascularization, with a strong relation between recurrent angina pectoris and progression of atherosclerotic disease in the native coronary arteries.23' 24 Angina pectoris after valve replacement recurs with the same frequency in patients who have undergone concomitant myocardial revascularization as in those who have not, so presumably, the percentage of patients in either group who require a second operation for relief of angina will also be similar. Finally, in patients with coronary artery disease and aortic valve disease, left ventricular wall tension and myocardial oxygen demand are increased, causing angina pectoris to appear earlier than it would during the course of coronary artery disease alone. After successful aortic valve replacement, with reduction in left ventricular mass and wall tension, the majority of patients become angina-free despite persistent critical coronary artery luminal narrowing. Thus, after aortic valve replacement plus revascularization, it is likely that the hemodynamic effects of valve replacement, not revascularization, are responsible for the relief of angina.
Prognosis after operation in certain subgroups of patients with combined aortic valvular and coronary artery disease may be enhanced by coronary artery bypass in addition to valve replacement. 
